Active cytomegalovirus retinitis after the start of antiretroviral therapy
Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first enter...
Main Authors: | , , , , , , |
---|---|
Format: | Journal article |
Published: |
BMJ Publishing Group
2018
|
_version_ | 1826303477360361472 |
---|---|
author | Heiden, D Tun, N Smithuis, F Keenan, J Oldenburg, C Holland, G Drew, W |
author_facet | Heiden, D Tun, N Smithuis, F Keenan, J Oldenburg, C Holland, G Drew, W |
author_sort | Heiden, D |
collection | OXFORD |
description | Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART. |
first_indexed | 2024-03-07T06:03:17Z |
format | Journal article |
id | oxford-uuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d52 |
institution | University of Oxford |
last_indexed | 2024-03-07T06:03:17Z |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | dspace |
spelling | oxford-uuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d522022-03-27T11:21:25ZActive cytomegalovirus retinitis after the start of antiretroviral therapyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d52Symplectic Elements at OxfordBMJ Publishing Group2018Heiden, DTun, NSmithuis, FKeenan, JOldenburg, CHolland, GDrew, WPatients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART. |
spellingShingle | Heiden, D Tun, N Smithuis, F Keenan, J Oldenburg, C Holland, G Drew, W Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title | Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title_full | Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title_fullStr | Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title_full_unstemmed | Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title_short | Active cytomegalovirus retinitis after the start of antiretroviral therapy |
title_sort | active cytomegalovirus retinitis after the start of antiretroviral therapy |
work_keys_str_mv | AT heidend activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT tunn activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT smithuisf activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT keenanj activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT oldenburgc activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT hollandg activecytomegalovirusretinitisafterthestartofantiretroviraltherapy AT dreww activecytomegalovirusretinitisafterthestartofantiretroviraltherapy |